Regulus Therapeutics Inc.’s RGLS share price has surged by 23.00%, which has investors questioning if this is right time to ...

Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® ...

APOL1-mediated kidney disease, IgA nephropathy, primary membranous nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes and myotonic dystrophy type 1. Vertex was founded in ...

for APOL1-mediated kidney disease, in phase 3, and early-stage candidate VX-407 for autosomal dominant polycystic kidney disease. Bank of America analysts said in a research note that the deal ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...

Background: Autosomal dominant polycystic kidney disease (ADPKD) is a hereditary kidney disorder mostly caused by mutations in PKD1 or PKD2 genes. Here, we report thirteen ADPKD males with infertility ...

A recent modeling study has identified risk factors predictive of good and bad outcomes in non-diabetic CKD, such as gender, ...

June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an ... Major Cause of Inflammatory ...

Jan. 27, 2025 — Heart disease remains the leading cause of death in the ... While Most Americans Use a Device to Monitor Their Heart, Few Share That Data With Their Doctor Jan. 22, 2025 — A ...

A potential correlation between polycystic ovary syndrome (PCOS ... Asthma, a chronic airway inflammatory disease with recurrence and reversibility, is characterized by paroxysmal wheezing, shortness ...

At least 10% of women of childbearing ages have polycystic ovary syndrome (PCOS), an endocrine ... High levels indicate an increased risk for cardiovascular disease. TG can become elevated due to ...